Sam-A Pharm. Co., Ltd (KOSDAQ:009300)

Market Cap	81.72B -21.9%
Revenue (ttm)	70.93B -21.3%
Net Income	8.89B -53.2%
EPS	1,455.84 -53.2%
Shares Out	6.10M
PE Ratio	9.20
Forward PE	n/a
Dividend	850.00 (6.58%)
Ex-Dividend Date	Dec 29, 2025

Volume	5,163
Open	13,140
Previous Close	12,910
Day's Range	13,000 - 13,700
52-Week Range	12,910 - 19,250
Beta	0.15
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Sam-A Pharm.

Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, antibiotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, ant-analgesics, gastro-intestinal, topical, oral, and anti-histamines. It provides NOMA MEGAFFECT for stress relief, eye care, memory and blood lipid con...

• Industry: Pharmaceutical Preparations
• Founded: 1945
• Employees: 305
• Stock Exchange: KOSDAQ
• Ticker Symbol: 009300

Financial Performance

In 2025, Sam-A Pharm.'s revenue was 77.80 billion, a decrease of -18.60% compared to the previous year's 95.58 billion. Earnings were 12.94 billion, a decrease of -41.39%.